Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T00:43:43.879Z Has data issue: false hasContentIssue false

Time to Detection in Culture Supports Prediction of Low Transmissibility of Tuberculosis and Discontinuation of Isolation for Low-Risk Patients With A Single AFB-Negative and NAAT-Negative Respiratory Specimen

Published online by Cambridge University Press:  19 March 2018

Saahir Khan*
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California
Audrey Nakasone
Affiliation:
Division of Medical Microbiology, Department of Pathology, University of California Irvine Health, Orange, California
Minoo Ghajar
Affiliation:
Public Health Laboratory
Mariam Zhowandai
Affiliation:
Pulmonary Disease Services, Orange County Health Care Agency, Santa Ana, California.
Sunita Prabhu
Affiliation:
Public Health Laboratory
Rick Alexander
Affiliation:
Public Health Laboratory
Julie Low
Affiliation:
Pulmonary Disease Services, Orange County Health Care Agency, Santa Ana, California.
Ellena Peterson
Affiliation:
Division of Medical Microbiology, Department of Pathology, University of California Irvine Health, Orange, California
Lauri Thrupp
Affiliation:
Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California Division of Medical Microbiology, Department of Pathology, University of California Irvine Health, Orange, California
*
Address correspondence to Lauri Thrupp, Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, 333 City Blvd West, The City Tower, Suite 400, Orange, CA 92868 (ldthrupp@uci.edu).

Abstract

For 94 patients with culture-positive pulmonary tuberculosis, time-to-detection (TTD), acid-fast bacilli (AFB) smear, and nucleic acid amplification test (NAAT) results were reviewed. All 12 patients whose first specimen was negative by AFB smear and NAAT had prolonged TTD, indicating low transmissibility and supporting discontinuing isolation for low-risk patients.

Infect Control Hosp Epidemiol 2018;39:619–621

Type
Concise Communications
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION. Some of these data were presented in brief as a poster at the ID Week conference on October 28, 2016, in New Orleans, Louisiana.

References

REFERENCES

1. Taylor, Z, Nolan, CM, Blumberg, HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recommend Rept CDC 2005;54:181.Google ScholarPubMed
2. Behr, MA, Warren, SA, Salamon, H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353:444449.CrossRefGoogle ScholarPubMed
3. Kalimuddin, S, Tan, JM, Tan, BH, Low, JG. A retrospective review of a tertiary Hospital’s isolation and de-isolation policy for suspected pulmonary tuberculosis. BMC Infect Dis 2014;14:547 doi: 10.1186/s12879-014-0547-7.CrossRefGoogle ScholarPubMed
4. Consensus statement on the use of Cepheid Xpert MTB/RIF assay in making decisions to discontinue airborne infection isolation in healthcare settings. National Tuberculosis Controllers Association, Association of Public Health Laboratories website. http://www.tbcontrollers.org/docs/resources/NTCA_APHL_GeneXpert_Consensus_Statement_Final.pdf. Published 2016. Accessed February 8, 2018.Google Scholar
5. O’Shea, MK, Koh, GCKW, Munang, M, Smith, G, Banerjee, A, Dedicoat, M. Time-to-detection in culture predicts risk of Mycobacterium tuberculosis transmission: a cohort study. Clin Infect Dis 2014;59:177185.CrossRefGoogle ScholarPubMed
6. Dinnes, J, Deeks, J, Kunst, H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007;11:1196.CrossRefGoogle ScholarPubMed
7. Choi, HW, Miele, K, Dowdy, D, Shah, M. Cost-effectiveness of Xpert(R) MTB/RIF for diagnosing pulmonary tuberculosis in the United States. Int J Tubercul Lung Dis 2013;17:13281335.CrossRefGoogle Scholar
8. Lippincott, CK, Miller, MB, Popowitch, EB, Hanrahan, CF, Van Rie, A. Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States. Clin Infect Dis 2014;59:186192.CrossRefGoogle ScholarPubMed
9. Marks, SM, Cronin, W, Venkatappa, T, et al. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis 2013;57:532542.CrossRefGoogle ScholarPubMed
10. Van den Wijngaert, S, Scheen, R, Vandenberg, O, Dediste, A. A prospective evaluation of selection criteria for the use of nucleic acid amplification techniques to test for the presence of Mycobacterium tuberculosis in respiratory tract samples. Clin Lab 2009;55:441446.Google ScholarPubMed